A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.17734 ◽

2021 ◽

Author(s):

A. Pinter ◽

LJ. Green ◽

J. Selmer ◽

M. Praestegaard ◽

L. Stein Gold ◽

...

Keyword(s):

Plaque Psoriasis ◽

Topical Treatment ◽

Pooled Analysis ◽

Betamethasone Dipropionate ◽

Fixed Dose ◽

Efficacy And Safety ◽

Phase 3 ◽

Randomized Controlled

Download Full-text

Long-term efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis sustained for three years: Results of a randomized controlled phase 3 study (UNCOVER-3)

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.05.732 ◽

2018 ◽

Vol 79 (3) ◽

pp. AB180

Keyword(s):

Plaque Psoriasis ◽

Efficacy And Safety ◽

Phase 3 ◽

Severe Plaque Psoriasis ◽

Randomized Controlled ◽

Term Efficacy

Download Full-text

Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2017.06.153 ◽

2017 ◽

Vol 77 (5) ◽

pp. 855-862 ◽

Cited By ~ 56

Author(s):

Andrew Blauvelt ◽

Melinda Gooderham ◽

Lars Iversen ◽

Susan Ball ◽

Lu Zhang ◽

...

Keyword(s):

Clinical Trial ◽

Plaque Psoriasis ◽

Efficacy And Safety ◽

Phase 3 ◽

Severe Plaque Psoriasis ◽

Randomized Controlled

Download Full-text

Efficacy and safety of apremilast with or without topical or phototherapy: Subanalysis of the population with < PASI-75 in the ESTEEM 1 phase 3, randomized, controlled trial in patients with moderate to severe plaque psoriasis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2016.02.963 ◽

2016 ◽

Vol 74 (5) ◽

pp. AB246 ◽

Cited By ~ 1

Keyword(s):

Randomized Controlled Trial ◽

Plaque Psoriasis ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Severe Plaque Psoriasis ◽

Randomized Controlled

Download Full-text

Efficacy and safety of interleukin-17 antagonists in patients with plaque psoriasis: a meta-analysis from phase 3 randomized controlled trials

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.14125 ◽

2017 ◽

Vol 31 (6) ◽

pp. 992-1003 ◽

Cited By ~ 8

Author(s):

D. Wu ◽

S.-Y. Hou ◽

S. Zhao ◽

L.-X. Hou ◽

T. Jiao ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Plaque Psoriasis ◽

Meta Analysis ◽

Controlled Trials ◽

Interleukin 17 ◽

Efficacy And Safety ◽

Phase 3 ◽

Randomized Controlled

Download Full-text

Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies

Journal of Clinical Lipidology ◽

10.1016/j.jacl.2009.02.007 ◽

2009 ◽

Vol 3 (2) ◽

pp. 125-137 ◽

Cited By ~ 22

Author(s):

Peter H. Jones ◽

Michael H. Davidson ◽

Anne C. Goldberg ◽

Carl J. Pepine ◽

Maureen T. Kelly ◽

...

Keyword(s):

Pooled Analysis ◽

Efficacy And Safety ◽

Fenofibric Acid ◽

Phase 3 ◽

Randomized Controlled ◽

Randomized Controlled Studies ◽

Mixed Dyslipidemia ◽

Three Phase

Download Full-text

The Efficacy and Safety of FMX101, Minocycline Foam 4%, for the Treatment of Acne Vulgaris: A Pooled Analysis of Phase 2 and Phase 3 Studies

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.1.supp.48 ◽

2017 ◽

Vol 1 ◽

pp. s49

Author(s):

Linda Stein Gold ◽

Sunil Dhawan ◽

Jonathan Weiss ◽

Zoe D Draelos ◽

Herman Ellman

Keyword(s):

Acne Vulgaris ◽

Pooled Analysis ◽

Phase 2 ◽

Efficacy And Safety ◽

Phase 3

Abstract Not Available

Download Full-text

Phase 3 Randomized, Controlled Trial of Switching to Fixed-dose Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from Boosted Protease Inhibitor-based Regimens in Virologically Suppressed Adults: Week 48 Results

10.26226/morressier.5aeaf2d35800a00019097f88 ◽

2018 ◽

Author(s):

Jürgen K. Rockstroh ◽

Christian Wisskirchen

Keyword(s):

Randomized Controlled Trial ◽

Protease Inhibitor ◽

Controlled Trial ◽

Fixed Dose ◽

Phase 3 ◽

Randomized Controlled ◽

Tenofovir Alafenamide

Download Full-text

Phase 3 randomized, controlled clinical trial of bictegravir coformulated with FTC/TAF in a fixed-dose combination (B/F/TAF) vs dolutegravir (DTG) + F/TAF in treatment-naïve HIV-1 positive adults: week 48 results

10.26226/morressier.5aeaf2d35800a00019097f85 ◽

2018 ◽

Author(s):

Christian Wisskirchen ◽

Hans-Jürgen Stellbrink

Keyword(s):

Clinical Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Controlled Clinical Trial ◽

Randomized Controlled Clinical Trial ◽

Phase 3 ◽

Randomized Controlled ◽

Treatment Naïve ◽

Dose Combination ◽

Hiv 1

Download Full-text

Faculty Opinions recommendation of Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 Trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733042913.793549527 ◽

2018 ◽

Author(s):

David Ginsberg

Keyword(s):

Nasal Spray ◽

Pooled Analysis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and Safety of Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam With Apremilast for Moderate Plaque Psoriasis

Journal of Drugs in Dermatology ◽

10.36849/jdd.2020.5020 ◽

2020 ◽

Vol 19 (9) ◽

pp. 874-880

Author(s):

Leon Kircik ◽

Todd Schlesinger ◽

Emil Tanghetti

Keyword(s):

Plaque Psoriasis ◽

Betamethasone Dipropionate ◽

Efficacy And Safety

Download Full-text